InvestorQ : What is the status of full approvals for Bharat Biotech’s Covaxin?
Arti Chavan made post

What is the status of full approvals for Bharat Biotech’s Covaxin?

Answer
image
Rutuja Nigam answered.
5 months ago
Follow

India’s first indigenous vaccine against Covid-19, Covaxin by Bharat Biotech, has just showed 77.6% efficacy in the final analysis of phase-3 clinical trials. The vaccine showed 93% efficacy rate against severe diseases and an impressive 60% efficacy against asymptomatic COVID-19. The final findings were presented before the Subject Expert Committee of DCGI and will also be presented to the WHO.

2 Views